Banki szczepionki przeciwko pryszczycy w Europie - stan obecny i perspektywy

• Autorzy: Niedbalski W , Kesy A.

Warianty tytułu

EN

Foot and mouth disease vaccine banks in Europe: present status and the future prospects

• Języki publikacji: PL

Abstrakty

EN

The article reviews the history, present status and the future of foot and mouth disease (FMD) vaccine banks in Europe. FMD vaccine banks are those holding reserves of fully formulated and tested vaccines ready for use, and those holding reserves of tested inactivated and concentrated antigen that can be formulated into vaccine. There are essentially four types of FMD vaccine banks in Europe: the International Vaccine Bank (IVB), the European Union Vaccine Bank (EUVB), the All Russian Research Institute for Animal Health (ARRIAH) Vaccine Bank and twelve National Government Vaccine Banks (NGVB). The establishing of these banks, their current location, consistent FMD virus serotypes and strains, as well as their utilization have been summarized. The most recent recommendations on FMD virus strains to be included in FMD vaccines banks, based on current epidemiological intelligence, have been presented. The turnover and replacement of banked antigen is necessary due to changes of FMD epidemiological situation. In an era of increasing global risk of the spread of FMD, vaccine banks will have a strategic role in the control and eradication of FMD.

Słowa kluczowe

PL

szczepionki przeciw pryszczycy; banki szczepionek; pryszczyca; zwalczanie chorob zwierzat; choroby zwierzat; Europa

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 04
• Opis fizyczny: s.394-398,rys.,tab.,bibliogr.

Twórcy

autor

Niedbalski W

• Panstwowy Instytut Weterynaryjny - Panstwowy Instytut Badawczy w Pulawach, ul.Wodna 7, 98-220 Zdunska Wola

autor

Kesy A.

Bibliografia

• 1.Adamowicz P. H., Legrand B., Guerche J., Prunet P.: Un nouveau procede de concentration et purification de virus. Application au virus de fievre aphteuse produit sur cellules BHK 21 pour l'obtention de vaccins hautement purifies. Bull. Off. Int. Epiz. 1974, 81, 1125-1150.
• 2.Anon.: Report of the Committee of Inquiry on Foot and Mouth Disease. Part 1. Her Majesty's Stationery Office, London, Cmnd 1969, 3999, 1-133.
• 3.Anon.: Council Decision of 11th December 1991 establishing Community reserves of foot and mouth disease vaccines (91/666/EEC).
• 4.Anon.: FMD situation in Europe: Balkans, Greece, Turkey and other regions. Report of the 32nd session of the European Commission for the control of foot and mouth disease (EUFMD), Rome, Italy 2-4 April 1997, s. 29-45.
• 5.Anon.: FMD vaccine and antigen bank situation in the European region: stocks held and future outlook. Report of the 36th session of the European Commission for the control of foot and mouth disease (EUFMD), Rome, Italy 27-29 April 2005, s. 24-26.
• 6.Barnett P. V., Samuel A. R., Statham R. J.: The suitability of the "emergency" foot-and-mouth antigens held by the International Vaccine Bank within a global context. Vaccine 2001, 19, 2107-2117.
• 7.Barnett P. V.: Report on the production of emergency O1 Manisa foot and mouth disease vaccine for the UK by the International Vaccine Bank (IVB). Report of the session of the research group of the standing technical committee of the of the European Commission for the control of foot and mouth disease (EUFMD), Island of Moen, Denmark 12-15 September 2001, s. 60-63.
• 8.Callis J.: Vaccine banks: present status and future developments. Report of the 62th general session of the Office International des Epizooties (OIE), Paris, France 16-20 May 1994, s. 1-6.
• 9.Donaldson A. I., Have P.: Criteria to consider and operational requirements for implementing emergency (ring) vaccination. Report of the session of the research group of the standing technical committee of the of the European Commission for the control of foot and mouth disease (EUFMD), Ma'ale Hachamisha, Israel 2-6 September 1996, s. 201-207.
• 10.Forman A. J., Garland A. J. M.: Foot and mouth disease: the future of vaccine banks. Rev. Sci. Tech. Off. Int. Epiz. 2002, 21, 601-612.
• 11.Garland A. J. M.: The availability of vaccines for emergency vaccination in Europe. Report of the 32nd session of the European Commission for the control of foot and mouth disease (EUFMD), Rome, Italy 2-4 April 1997, s. 89-111.
• 12.Knowles N. J., Samuel A. R.: Molecular epidemiology of foot and mouth disease virus. Virus Res. 2003, 91, 65-80.
• 13.Leforban Y.: The availability of vaccines for emergency vaccination in Europe. Report of the 31st session of the European Commission for the control of foot and mouth disease (EUFMD), Rome, Italy 5-7 April 1997, s. 60-65.
• 14.Mason P. W., Pacheco J. M., Zhao Q. Z., Knowles N. J.: Comparison of the complete genomes of Asian, African and European isolates of a recent foot-and-mouth disease virus type O pandemic strain (PanAsia). J. Gen. Virol. 2003, 84, 1583-1593.
• 15.Murray P. K.: A review of foot and mouth disease international vaccine banks, [w:] Nunn M. J., Thornber P. M. (eds): Proc. National Symposium on Foot and Mouth Disease. Australian Government Publication Service, Canberra 8-10 September 1992, s. 115-123.
• 16.Niedbalski W., Wijaszka T., Kęsy A.: Szczepionki markerowe - nowe możliwości zapobiegania i zwalczania pryszczycy. Medycyna Wet. 2003, 59, 279-282.
• 17.Pluimers F. H.: Eradication of foot-and-mouth disease in the Netherlands by emergency vaccination and the trade implications. Report of the conference: Foot-and-mouth disease. Control strategies, Lyons, France 2-5 June 2002, s. 63.
• 18.Ryan J.: The availability of foot-and-mouth disease vaccines for emergency vaccination in Europe. Report of the 33th session of the European Commission for the control of foot and mouth disease (EUFMD), Rome, Italy 7-9 April 1999, s. 82-89.
• 19.Ryan J.: The availability of foot-and-mouth disease vaccines for emergency vaccination in Europe. Report of the 34th session of the European Commission for the control of foot and mouth disease (EUFMD), Rome, Italy 21-24 March 2001, s. 117-121.
• 20.Salt J. S., Barnett P. V., Dani P., Williams L.: Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 1998, 16, 746-754.
• 21.Wijaszka T.: Pryszczyca 2001 - problemy szczepień u zwierząt. Medycyna Wet. 2001, 57, 383-385.
• 22.Zakharow V. M., Baibikov T. Z., Rakhmanov A. M., Dudnikov A. I.: Foot and mouth disease control strategies in the Russian Federation and ex-USSR countries. Report of the meeting of the research group of the standing technical committee of the of the European Commission for the control of foot and mouth disease (EUFMD), Vladimir, Russian Federation 20-22 September 1995, s. 81-83.